PHARMARON (EXTON) LAB SERVICES LLC

QUANTITATION OF GM1 IN HUMAN CSF USING METHOD FROM STUDY 20AXOVP6 (GLP)-ROLLING SAMPLE ANALYSIS.

IN-VIVO PK STUDY IN ORDER TO DETERMINE THE OPTIMAL FORMULATION TO DOSE CYTOCHROME P INHIBITORS AND ANALYZE THEIR CONCENTRATIONS IN MOUSE PLASMA

AMENDMENT TO ORIGINAL CONTRACT DUE TO THE CHANGE IN THE SCOPE OF WORK AND FUNDING. ALL OTHERS REMAINS UNCHANGED. IN-VIVO PK STUDY IN ORDER TO OBTAIN PRELIMINARY PHARMACOKINETICS (PK) TO JUSTIFY IN VIVO EXPERIMENTS FOR THE HIV ASO PROJECT.

IN-VIVO PK STUDY IN ORDER TO OBTAIN PRELIMINARY PHARMACOKINETICS (PK) TO JUSTIFY IN VIVO EXPERIMENTS FOR THE HIV ASO PROJECT.

RATIFICATION OF AN UNAUTHORIZED COMMITMENT FOR CHEMICAL SUPPLY PRODUCT (ZERO PERMEABILITY MARKER LUCIFER YELLOW).